| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.1M | -83.6% |
| Cost of Revenue | $513K | -90.0% |
| Gross Profit | $631K | -65.9% |
| R&D Expense | $3.6M | +2.3% |
| SG&A Expense | $1.3M | -79.1% |
| Operating Income | -$7.1M | +35.3% |
| Interest Expense | $1.9M | +89.1% |
| Pre-tax Income | -$9.2M | +23.9% |
| Net Income | -$10.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $143K | -83.7% |
| Current Assets | $1.9M | +35.2% |
| Total Assets | $2.6M | +9.6% |
| Current Liabilities | $6.8M | -8.5% |
| Long-term Debt | $13.7M | +76.7% |
| Total Liabilities | $19.7M | +54.5% |
| Stockholders' Equity | -$17.2M | -64.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.1M | +24.8% |
| Capital Expenditures | $5K | -72.0% |
| Investing Cash Flow | -$13K | +18.0% |
| Financing Cash Flow | $6.8M | -15.4% |
| Free Cash Flow | -$6.1M | +24.9% |
| +15.2% |
| EPS (Basic) | -$0.15 | +16.7% |
| EPS (Diluted) | -$0.15 | +16.7% |